Stanford University — Universal Flu Drug Research (Jeffrey Glenn)

Organization Name 
Award Date 
7/2020
Grant Amount 
$415,000
Purpose 
To test the efficacy of a universal antiviral drug candidate against all influenza strains.
Topic (focus area) 

Grant investigators: Heather Youngs and Chris Somerville

This page was reviewed but not written by the grant investigators. Stanford University staff also reviewed this page prior to publication.

Open Philanthropy recommended a grant of $415,000 to Stanford University to support work led by Professor Jeffrey Glenn to test the efficacy of a universal antiviral drug candidate against all influenza strains. An effective pan-influenza antiviral drug could avert hundreds of thousands of deaths annually and minimize the spread of highly infectious and lethal strains of the virus. Professor Glenn intends to use this funding to conduct protective assays in ferrets, a transmission study, and a pharmacokinetics and distribution analysis.

This follows our June 2020 support and falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.